Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

<< Previous

Bullboard Posts

Next >>

Post by lonc17on Dec 13, 2023 11:53am

227 Views

Post# 35782296

Good job Matt

Congratulations Matt!

By the end of day today you will be the proud owner of 175,000 freshly minted ONC shares.

175,000 * $1.45 seems like a lot of money to pay for these shares, but you have no reason to worry because Oncolytics Biotech is a leading company in cancer research and it is only months away from a P3 and partnership with a major pharma.

Hang on to those shares Matt... they're sure to be a great addition to your portfolio.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing